<DOC>
	<DOCNO>NCT00208312</DOCNO>
	<brief_summary>Adenoscan® ( adenosine ) approve pharmacological stress agent indicate adjunct thallium-201 myocardial perfusion scintigraphy patient unable exercise adequately . The investigational drug , regadenoson ( CVT-3146 ) selective A2A adenosine receptor agonist , receptor responsible coronary vasodilation , study potential use pharmacologic stress agent myocardial perfusion imaging ( MPI ) study . This study compare safety efficacy regadenoson Adenoscan detect reversible myocardial perfusion defect .</brief_summary>
	<brief_title>ADVANCE MPI 2 : Study Regadenoson Versus Adenoscan® Patients Undergoing Myocardial Perfusion Imaging ( MPI )</brief_title>
	<detailed_description>ADVANCE MPI 2 multi-national , double-blind , randomize , active-controlled , parallel group clinical trial evaluate safety efficacy regadenoson SPECT MPI compare approve pharmacological stress agent , Adenoscan . Patients refer clinically indicated pharmacological stress MPI study eligible enrollment . The trial design : ( 1 ) compare pharmacological stress SPECT image obtain regadenoson obtain Adenoscan , ( 2 ) compare safety tolerability two stress agent .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<mesh_term>Regadenoson</mesh_term>
	<criteria>Referred clinically indicated pharmacological stress SPECT myocardial perfusion image study Any condition preclude safe administration Adenoscan SPECT myocardial perfusion image study Pregnant breastfeeding , ( premenopausal ) , practice acceptable method birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Lexiscan</keyword>
	<keyword>Regadenoson</keyword>
	<keyword>Adenoscan®</keyword>
	<keyword>Adenosine</keyword>
	<keyword>SPECT Myocardial Perfusion Imaging</keyword>
	<keyword>Reversible Perfusion Defect</keyword>
</DOC>